KALA - Kala Pharmaceuticals EPS misses by $0.03 misses on revenue February, 12 2020 07:06 AM Kala Pharmaceuticals Inc. Kala Pharmaceuticals (NASDAQ:KALA): Q4 GAAP EPS of -$0.63 misses by $0.03.More news on: Kala Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...